Submissions from 2024
Tech Note 2024-1 A Novel Framework to Estimate Social and Private Value Created Through Commercialization of a Pharmaceutical Product, Paula Chaves de Silva and Fred D. Ledley
Comments Re: Draft Guidance Considering Exercise of March-In Rights - Docket No.: 230831-0207, Fred D. Ledley and Edward Zhou
Submissions from 2023
Response to "Department of Commerce, National Institute of Standards and Technology, Agency Information Collection Activities", Fred D. Ledley
Tech Note 2023-1 NIH Contribution to Phased Clinical Development of Drugs Approved from 2010-2019, Edward Zhou, Matthew Jackson, and Fred Ledley
Submissions from 2020
Characterizing the public sector contribution to drug discovery and development: the role of government as a first investor, Ekaterina Galkina Cleary, Matthew Jackson, Andrew Acevedo, and Fred D. Ledley